Spectral AI Completes Data Analysis for U.S. Burn Study
February 10, 2025
Spectral AI, developer of the AI-driven DeepView System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral